tiprankstipranks
Trending News
More News >
Neurogene Inc. (NGNE)
:NGNE
US Market

Neurogene (NGNE) Income Statement

Compare
554 Followers

Neurogene Income Statement

Last quarter (Q1 2025), Neurogene's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Neurogene's net income was $-22.65M. See Neurogene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 925.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.32M$ -3.26M$ -3.20M$ -2.28M$ -1.82M
Operating Expenses
$ 83.53M$ 55.58M$ 56.52M$ 50.53M$ 39.73M
Depreciation and Amortization
$ 3.25M$ 3.30M$ 3.20M$ 2.28M$ 1.82M
EBITDA
$ -71.89M$ -52.29M$ -51.99M$ -49.59M$ -31.46M
Operating Income
$ -82.61M$ -55.58M$ -56.52M$ -50.53M$ -41.55M
Other Income/Expenses
$ 7.46M$ 19.27M$ 1.33M$ 17.00K$ 8.28M
Pretax Income
$ -75.14M$ -36.32M$ -55.19M$ -50.52M$ -33.28M
Net Income
$ -75.14M$ -36.32M$ -55.19M$ -50.52M$ -33.28M
Per Share Metrics
Basic EPS
$ -4.43$ -2.83$ -4.30$ -0.92$ -0.64
Diluted EPS
$ -4.43$ -2.83$ -4.30$ -0.92$ -0.64
Weighted Average Shares Outstanding
17.57M 12.82M 12.82M 55.04M 51.83M
Weighted Average Shares Outstanding (Diluted)
17.57M 12.82M 12.82M 55.04M 51.83M
Currency in USD

Neurogene Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis